The E. coli alpha-hemolysin secretion system and its use in vaccine development.
about
Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide.Use of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in miceCoiled-coil protein composition of 22 proteomes--differences and common themes in subcellular infrastructure and traffic controlA calcium-gated lid and a large beta-roll sandwich are revealed by the crystal structure of extracellular lipase from Serratia marcescensStrategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli.Enhancement of the efficiency of secretion of heterologous lipase in Escherichia coli by directed evolution of the ABC transporter system.ATP-binding cassette systems in Burkholderia pseudomallei and Burkholderia mallei.Type V protein secretion pathway: the autotransporter storyIon selectivity of alpha-hemolysin with a beta-cyclodextrin adapter. I. Single ion potential of mean force and diffusion coefficientPrevalence of pathogenicity island IICFT073 genes among extraintestinal clinical isolates of Escherichia coliAdhesive polypeptides of Staphylococcus aureus identified using a novel secretion library technique in Escherichia coli.Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coliCharacterization of a resistance-nodulation-cell division transporter system associated with the syr-syp genomic island of Pseudomonas syringae pv. syringae.Insight into cross-talk between intra-amoebal pathogens.Excretion of human beta-endorphin into culture medium by using outer membrane protein F as a fusion partner in recombinant Escherichia coli.Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity.Ion permeation through the alpha-hemolysin channel: theoretical studies based on Brownian dynamics and Poisson-Nernst-Plank electrodiffusion theoryPathogenicity islands in bacterial pathogenesisPossible role of Escherichia coli in propagation and perpetuation of chronic inflammation in ulcerative colitisLive bacterial vaccine vectors: an overview.Antibodies against hemolysin and cytotoxic necrotizing factor type 1 (CNF1) reduce bladder inflammation in a mouse model of urinary tract infection with toxigenic uropathogenic Escherichia coli.TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitansExtracellular overexpression of recombinant Thermobifida fusca cutinase by alpha-hemolysin secretion system in E. coli BL21(DE3)Enteric pathogens as vaccine vectors for foreign antigen deliveryCharacterization of a novel microcin that kills enterohemorrhagic Escherichia coli O157:H7 and O26.Engineered bacterial outer membrane vesicles with enhanced functionalityType 1 protein secretion in bacteria, the ABC-transporter dependent pathway (review).How we got attached to Actinobacillus actinomycetemcomitans: A model for infectious diseases.New technologies in developing recombinant attenuated Salmonella vaccine vectors.Screen for leukotoxin mutants in Aggregatibacter actinomycetemcomitans: genes of the phosphotransferase system are required for leukotoxin biosynthesisExploiting cholera vaccines as a versatile antigen delivery platformExploratory Investigation of Bacteroides fragilis Transcriptional Response during In vitro Exposure to Subinhibitory Concentration of Metronidazole.Nanoparticle-detained toxins for safe and effective vaccination.Common and pathogen-specific virulence factors are different in function and structure.A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infectionRhizobium leguminosarum has a second general amino acid permease with unusually broad substrate specificity and high similarity to branched-chain amino acid transporters (Bra/LIV) of the ABC family.Involvement of a novel efflux system in biofilm-specific resistance to antibiotics.Two outer membrane proteins are required for maximal type I secretion of the Caulobacter crescentus S-layer protein.Improved secretory production of recombinant proteins by random mutagenesis of hlyB, an alpha-hemolysin transporter from Escherichia coli.The rate of folding dictates substrate secretion by the Escherichia coli hemolysin type 1 secretion system.
P2860
Q24535758-C1ABAF4F-906F-4393-85C9-044FDEF53590Q24806827-CF64EE0A-D9D3-4058-97AC-12F22142E0FAQ24814202-064E04EF-D7BB-472A-BD55-4698F15BF75DQ27647647-C446F9B5-6174-45B6-99AF-5DFAA8527D8CQ30377057-A57FD03A-1C2C-40DB-9A1A-8674DDB44BEAQ33218342-9171D401-3A4D-4906-8480-8C3D2796EDC0Q33280317-9B29C881-E0FA-4738-9A9D-3D8626CDC910Q33559645-2BF3BC9B-74A0-462C-8B1A-D38F3E999950Q33761288-8CF1C437-5B1A-45C4-9ACC-1925D0CA3A7BQ33859263-01C2E163-5958-4702-B2D8-C018379E4AF9Q33913148-405FBA98-B412-4D2D-A47E-DBA5366A852FQ33927393-8725DB3F-8696-4DF8-B20D-CF3EC57F6311Q33995877-D14CF15F-442A-421D-B76E-DEE18EB688F0Q34065404-0278B6CC-A1D3-469B-BA73-A1AB507A5EA8Q34095717-E1ECABFB-584D-418B-8A03-381CFA63623EQ34119481-A63CEC05-81C5-4F6C-92BB-B926EB08C81BQ34187301-ED3CD8D5-36B8-4DEF-AACB-95169ABD6268Q34290188-CB894D91-0B86-4A11-AC6C-5F180C52D938Q34659160-8B73805D-80B2-49AD-912E-D8CFC7E81FD0Q35068970-BD897829-269C-4971-811C-56AA9D4EC8E9Q35187543-B6040556-B2AD-4503-85ED-2742789747C8Q35696412-0C3AABEF-BC56-412F-9A7D-ABAF361ABB04Q35777093-7A1BFE79-9F1C-4252-8696-706A9EEB5D32Q35896020-9E24B39E-BD11-4886-BB7E-9CBC997C0D5AQ36186173-CA7556A5-71D3-45E0-8844-65543F1C06EAQ36198257-2FE433D2-B71A-45F6-874B-526C31337DEEQ36224495-3C490C3D-8CAA-4808-8BC4-7AE762A626E2Q36575953-B649682A-83AE-420A-88A2-5E2B8E651141Q36653379-AF8A91D6-311F-4937-A8CC-AFE46592E994Q36804347-78C9CC41-1FA0-48CD-8FF4-21C307826471Q37002887-F15E8624-72E6-418B-BA1A-DD90FEEDFED5Q37266199-1964AE53-7280-4E9F-8F44-CE6CC8629AB3Q37426321-FF512AF0-6966-4FA4-9D90-9EDA1FB6BCB4Q37713156-8EF9CA70-AD00-4EEB-9AAE-028EFB9FB2F6Q39015820-1134040F-A793-4B60-AE2C-F64C47533712Q39679783-E7C61F0D-5D63-4C67-8ED3-E156A78A43A5Q39759278-CFF05AA7-41A1-4F52-A8A8-707032C4AF38Q40420288-153D3B32-9ABD-481C-AEB3-4DB6B1CA7316Q40981516-9CBDA16B-485B-40E4-88B1-1B8AC5850025Q41197368-36DEF2D8-1666-4279-9FEE-BA01EF17BB19
P2860
The E. coli alpha-hemolysin secretion system and its use in vaccine development.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The E. coli alpha-hemolysin secretion system and its use in vaccine development.
@ast
The E. coli alpha-hemolysin secretion system and its use in vaccine development.
@en
The E. coli alpha-hemolysin secretion system and its use in vaccine development.
@nl
type
label
The E. coli alpha-hemolysin secretion system and its use in vaccine development.
@ast
The E. coli alpha-hemolysin secretion system and its use in vaccine development.
@en
The E. coli alpha-hemolysin secretion system and its use in vaccine development.
@nl
prefLabel
The E. coli alpha-hemolysin secretion system and its use in vaccine development.
@ast
The E. coli alpha-hemolysin secretion system and its use in vaccine development.
@en
The E. coli alpha-hemolysin secretion system and its use in vaccine development.
@nl
P2093
P1476
The E. coli alpha-hemolysin secretion system and its use in vaccine development.
@en
P2093
Guido Dietrich
Ivaylo Gentschev
Werner Goebel
P356
10.1016/S0966-842X(01)02259-4
P577
2002-01-01T00:00:00Z